| 22nd Feb 2023 7:52 am |
RNS |
Holding(s) in Company |
| 6th Feb 2023 7:02 am |
RNS |
Holding(s) in Company |
| 31st Jan 2023 5:00 pm |
RNS |
Total Voting Rights |
| 24th Jan 2023 12:48 pm |
RNS |
Holding(s) in Company |
| 20th Dec 2022 3:17 pm |
RNS |
Update re. timing of Admission |
| 19th Dec 2022 7:00 am |
RNS |
Put Option re AZD1656 & £115,586 Subscription |
| 23rd Nov 2022 8:04 am |
RNS |
Clinical Study for Lung Cancer Detection in China |
| 9th Nov 2022 7:00 am |
RNS |
Conduit Pharmaceuticals Proposed Listing |
| 31st Oct 2022 5:00 pm |
RNS |
Total Voting Rights |
| 4th Oct 2022 8:00 am |
RNS |
Admission and Total Voting Rights |
| 30th Sep 2022 5:00 pm |
RNS |
Total Voting Rights |
| 29th Sep 2022 3:49 pm |
RNS |
Issue of Consideration Shares & Option Exercise |
| 28th Sep 2022 3:05 pm |
RNS |
Holding(s) in Company |
| 28th Sep 2022 7:00 am |
RNS |
Interim results |
| 26th Sep 2022 8:00 am |
RNS |
Admission and Total Voting Rights |
| 21st Sep 2022 11:23 am |
RNS |
Subscription, Facility & Publication of Prospectus |
| 18th Aug 2022 9:21 am |
RNS |
Arcadia Clinical Trial Results Published |
| 10th Aug 2022 4:41 pm |
RNS |
Second Price Monitoring Extn |
| 10th Aug 2022 4:36 pm |
RNS |
Price Monitoring Extension |
| 11th Jul 2022 7:15 am |
EQS |
Hardman & Co Research: Cizzle Biotechnology (CIZ): Considerable progress in first year since listing |
| 5th Jul 2022 7:00 am |
RNS |
Update on Development of Proprietary Antibodies |
| 27th Jun 2022 11:52 am |
RNS |
Result of AGM |
| 16th Jun 2022 7:00 am |
RNS |
Marketing Agreement to Enhance Expansion in the US |
| 1st Jun 2022 7:00 am |
RNS |
Posting of Annual Report and Notice of AGM |
| 30th May 2022 7:00 am |
RNS |
Results for the year ended 31 December 2021 |
| 6th May 2022 9:05 am |
RNS |
Second Price Monitoring Extn |
| 6th May 2022 9:00 am |
RNS |
Price Monitoring Extension |
| 6th May 2022 7:00 am |
RNS |
Strategic Alliance re lung cancer detection in USA |
| 11th Apr 2022 7:00 am |
RNS |
Further Research Agreement with University of York |
| 31st Mar 2022 5:28 pm |
RNS |
Holding(s) in Company |
| 22nd Mar 2022 4:40 pm |
RNS |
Second Price Monitoring Extn |
| 22nd Mar 2022 4:35 pm |
RNS |
Price Monitoring Extension |
| 22nd Mar 2022 2:05 pm |
RNS |
Second Price Monitoring Extn |
| 22nd Mar 2022 2:00 pm |
RNS |
Price Monitoring Extension |
| 7th Mar 2022 7:00 am |
RNS |
Positive outcomes from Arcadia Trial re AZD1656 |
| 28th Feb 2022 5:00 pm |
RNS |
Total Voting Rights |
| 18th Feb 2022 3:56 pm |
RNS |
Holding(s) in Company |
| 16th Feb 2022 3:23 pm |
RNS |
Total Voting Rights |
| 14th Feb 2022 7:00 am |
RNS |
Royalty Acquisition Agreement |
| 8th Feb 2022 12:15 pm |
EQS |
Hardman & Co Research: Cizzle Biotechnology (CIZ) Strategic alliance in China |
